Clorgiline
| Clinical data | |
|---|---|
| Other names | Clargyline |
| Drug class | Monoamine oxidase inhibitor; MAO-A inhibitor |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H15Cl2NO |
| Molar mass | 272.17 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Clorgiline (INN), or clorgyline (BAN), is a monoamine oxidase inhibitor (MAOI) and investigational antidepressant related to pargyline. Specifically, it is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A). Clorgiline was never marketed, but it has found use in scientific research.
In addition to its MAOI activity, it has been found to bind with high affinity to the σ1 receptor (Ki = 3.2–510 nM) and with very high affinity to the imidazoline I2 receptor (Ki = 40 pM). Unlike selegiline, clorgiline does not appear to be a monoaminergic activity enhancer (MAE).
Clorgiline is also a multidrug efflux pump inhibitor. Holmes et al., 2012 reverse azole fungicide resistance using clorgiline, showing promise for its use in multiple fungicide resistance.